Approximately 20% of HCCs and BTCs are theoretically good candidates for ICIs based on their high level of expression of programmed death-ligand 1 (PD-L1) and tumor-infiltrating lymphocytes (TILs) [15,16]. Here, CD274 is linked to neoplasm.